4th Quarter - Report

BOCKORNY GROUP, INC. for CVS HEALTH INC

Firm
Client
Income
$120,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues related to corporate tax policy reform Issues related to taxes on employee health plans H.R.1 - Tax Cuts and Jobs Act of 2017

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
DANIEL FERNANDEZ —
BRAD HANTLER —
ALLEN JONES JAMERSON —
NICOLE VENABLE —

Contacted: Executive Office of the President (EOP); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; White House Office

Bills named: H.R. 1 (115th)

Pharmacy PHA

Issues related to PBM's Issues related to drug supply chain Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals S.637 - Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017 H.R.2212 - CREATES Act of 2017 Judiciary issues related to the drug supply chain

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
DANIEL FERNANDEZ —
BRAD HANTLER —
ALLEN JONES JAMERSON —
NICOLE VENABLE —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; White House Office

Bills named: S. 637 (115th), H.R. 2212 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.